There’s a lot of buzz about cannabis becoming legal for adult recreational use in Canada on October 17th. But how will full legalization change the way that medical cannabis users access and use their now legal medication? And what should be done to make the system work better for patients? Watch as our panel of experts discuss how the system currently works, what lessons we can learn from experiences in Canada and abroad, and what the future might hold for medical cannabis and the patients who rely on it.
Panel on The Future of Medical Cannabis
The panel event was held in Zoomer Hall on Wednesday, October 10. Libby Znaimer was moderator and the panelists were:
Dr. Danial Schecter, a family physician, medical cannabis expert and Chief Medical Officer of the Cannabinoid Medical Clinic.
Janet Yale, president and CEO of The Arthritis Society.
Moses Znaimer, President of CARP and founder of ZoomerMedia
Dr. David Casarett, a palliative care physician, member of the Duke Cancer Institute at Duke University School of Medicine, and health services researcher.
Andre Picard, health columnist for The Globe and Mail.
Michael Boivin, a clinical pharmacist consultant and leader in medical cannabis education.